Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment

  title={Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment},
  author={Jordan P. Davis and Douglas Cary Smith and Jason W. Morphew and Xinrong Lei and Saijun Zhang},
  journal={Journal of Drug Issues},
  pages={64 - 83}
Very little prospective research investigates how cannabis withdrawal is associated with treatment outcomes, and this work has not used the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) thresholds for cannabis withdrawal. The sample included 110 emerging adults entering outpatient substance use treatment who were heavy cannabis users with no other drug use and limited alcohol use. We used survival analyses to predict days to first use of cannabis and logistic regression… 

Figures and Tables from this paper

The cannabis withdrawal syndrome: current insights
The cannabis withdrawal syndrome (CWS) is a criterion of cannabis use disorders (CUDs) (Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition) and cannabis dependence (ICD]-10 and the up-to-date ICD-11 Beta Draft is recommended to be expanded by physical CWS symptoms, the specification of CWS intensity and duration as well as gender effects.
Clinical management of cannabis withdrawal
The clinical significance of cannabis withdrawal is that its symptoms may precipitate relapse to cannabis use and complicated withdrawal may occur in people with concurrent mental health and polysubstance use.
Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids
Cannabis withdrawal syndrome appears to be common among regular users of cannabis, particularly those in outpatient and inpatient settings and individuals with substance use disorders; clinicians should be aware of the high prevalence of cannabis withdrawal syndrome to counsel patients and support individuals who are reducing their use of cannabis.
Cannabis use and cannabis use disorder
The epidemiology of cannabis use is reviewed, together with the epidemiology, mechanisms, diagnosis, prevention and treatment of Cannabis use disorder, and the risks associated with high-potency cannabis products are discussed.
Gender differences among treatment‐seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation—evaluating N‐acetylcysteine treatment (ACCENT) study
Cannabis-dependent women may benefit from integrated treatment focusing on co-occurring psychiatric disorders and targeted treatment of cannabis withdrawal syndrome, and may help explain recent evidence suggesting that women fare worse than men in cannabis treatment trials of pharmacologic interventions.
Cannabis Use Disorder Treatment and Reimbursement
The purpose of the current chapter is to review available literature on access to and reimbursement of treatments for CUDs and include the opinion of treatment payers about treatments and insights for researchers and medication development sponsors.
Cannabis Withdrawal: a Review of Neurobiological Mechanisms and Sex Differences
Pre-clinical and clinical research on the etiology and biological substrates of the cannabis withdrawal syndrome are provided, and females have been shown to have increased rate and severity of a subset of cannabis withdrawal symptoms compared with men.


Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.
This is the first follow-up study on the association between cannabis withdrawal symptoms and risk of relapse to cannabis use and offers further validation of a cannabis withdrawal syndrome.
Quantifying the Clinical Significance of Cannabis Withdrawal
Cannabis withdrawal is clinically significant because it is associated with functional impairment to normal daily activities, as well as relapse to cannabis use.
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.
Cannabis withdrawal in adolescent treatment seekers.
Cannabis withdrawal among non-treatment-seeking adult cannabis users.
Study findings provide evidence for the clinical significance of a cannabis withdrawal syndrome, based on the high prevalence and co-occurrence of multiple symptoms that follow a consistent time course and that prompt action by the subjects to obtain relief, including serving as negative reinforcement for cannabis use.
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.
Abstinence symptoms were generally more intense in the initial phase, implying importance of early intervention in cannabis quit attempts and sleep disturbance persisting for an extended period suggests that hypnotic medications could be beneficial in treating cannabis dependence.
Diagnostic criteria for cannabis withdrawal syndrome.